Journal
/
Bioquímica
/
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
JoVE Revista
Bioquímica
Se requiere una suscripción a JoVE para ver este contenido.  Inicie sesión o comience su prueba gratuita.
JoVE Revista Bioquímica
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

3,049 Views

•

08:48 min

•

November 05, 2021

DOI:

10.3791/63210-v

DOI:
10.3791/63210-v

•

08:48 min
November 05, 2021

•

3 Views
, , , , ,
1Área Parasitología, Facultad de Ciencias Bioquímicas y Farmacéuticas,Universidad Nacional de Rosario (UNR), 2Instituto de Biología Molecular y Celular de Rosario (IBR),CONICET, 3Instituto de Investigaciones Biomédicas (INBIOMED),Universidad de Buenos Aires (UBA) Facultad de Medicina, CONICET

Summary

Automatically generated

We describe a high-throughput colorimetric assay measuring β-galactosidase activity in three life cycle stages of Trypanosoma cruzi, the causative agent of Chagas disease. This assay can be used to identify trypanocidal compounds in an easy, fast, and reproducible manner.

Explore More Videos

Trypanosoma CruziIn Vitro Drug ScreeningHigh-throughput Colorimetric AssayParasite Life Cycle StagesEpimastigotesTrypomastigotesVero CellsBeta-galactosidaseChagas DiseaseDrug Discovery

Read Article

Cite this Article

Alonso, V. L., Manarin, R., Perdomo, V., Gulin, E., Serra, E., Cribb, P. In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase. J. Vis. Exp. (177), e63210, doi:10.3791/63210 (2021).

Download .ris file

Copy

Share Video

.

Copy